Oyamada Shogo, Takahashi Masahiro, Furutate Sakiko, Oka Shinichirou, Kubota Eri, Sakurai Azusa, Uekusa Tomoko, Watanabe Kana, Iwasaki Satoshi
Department of Otorhinolaryngology, Mita Hospital, International University of Health and Welfare, Tokyo, Japan.
Otol Neurotol. 2023 Apr 1;44(4):331-338. doi: 10.1097/MAO.0000000000003830.
Cochlear implantation (CI) for the treatment of single-sided deafness (SSD) is a relatively new treatment modality. Although comparing the effectiveness of CI and contralateral routing of signal (CROS) hearing aids (HAs) is important, very few reports on this topic exist. In this study, objective assessments and subjective assessments were conducted to determine which SSD individuals would prefer CI or CROS HAs.
Objective assessments (speech perception and sound localization) and subjective assessments (Hearing Handicap Inventory for Adults (HHIA), Abbreviated Profile of Hearing Aid Benefit (APHAB), MOS Short-Form 36-Item Health Survey version 2 (SF-36v2)) were performed on 87 SSD patients. Of the 87 SSD patients, 33 patients hoped for CROS HAs, and 17 patients hoped for CI. The CI group underwent subjective and objective assessments at 6 and 12 months postoperatively. The CROS HAs group underwent objective assessments at 1 month after wearing CROS HAs.
After the intervention, the localization ability was significantly improved in the CI group (p < 0.05) with no significant improvement in that of the CROS HAs group (p = 0.48). No significant improvement in speech perception in noise was observed in the CROS (Signal-to-Noise ratio + 10, p = 0.08; SN + 0, p = 0.17); however, a significant improvement in the CI group was observed at 12 months postoperatively. The APHAB subscale "background noise" and SF-36v2 health concepts of role-physical, general health, vitality, role-emotional, and mental health were significantly higher in the CI group.
CI was superior to CROS HAs in speech perception in terms of noise and sound localization. Patients with postlingual acute-onset hearing loss and more handicaps and a more positive view of their hearing loss possibly tend to choose CI.
人工耳蜗植入(CI)用于治疗单侧耳聋(SSD)是一种相对较新的治疗方式。尽管比较CI与对侧信号路由(CROS)助听器(HA)的有效性很重要,但关于该主题的报道极少。在本研究中,进行了客观评估和主观评估,以确定哪些SSD患者会更倾向于选择CI或CROS HA。
对87例SSD患者进行了客观评估(言语感知和声音定位)和主观评估(成人听力障碍量表(HHIA)、助听器受益简表(APHAB)、医学结局研究简明健康调查简表第2版(SF - 36v2))。在这87例SSD患者中,33例患者希望使用CROS HA,17例患者希望接受CI。CI组在术后6个月和12个月进行了主观和客观评估。CROS HA组在佩戴CROS HA 1个月后进行了客观评估。
干预后,CI组的定位能力显著提高(p < 0.05),而CROS HA组无显著改善(p = 0.48)。CROS组在噪声中的言语感知无显著改善(信噪比 + 10,p = 0.08;SN + 0,p = 0.17);然而,CI组在术后12个月观察到显著改善。CI组的APHAB分量表“背景噪声”以及SF - 36v2健康概念中的角色 - 身体、总体健康、活力、角色 - 情感和心理健康得分显著更高。
在噪声言语感知和声音定位方面,CI优于CROS HA。语后急性发作性听力损失、残疾程度更高且对听力损失看法更积极的患者可能更倾向于选择CI。